Department of Endocrinology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, People's Republic of China.
Department of Endocrinology, The First People's Hospital of Xuzhou, Xuzhou, 221000, People's Republic of China.
BMC Nephrol. 2022 Jul 27;23(1):270. doi: 10.1186/s12882-022-02888-3.
Currently, there is a lack of clinical indicators that can accurately distinguish diabetic kidney disease (DKD) from non-diabetic kidney disease (NDKD) in type 2 diabetes. The purpose of this study was to investigate the diagnostic value of triglyceride and cystatin C (TG/ Cys-C) ratio in DKD. Nowadays, there are few studies on the differential diagnosis of TG/ Cys-C ratio between DKD and NDKD.
The clinical data of patients with type 2 diabetes complicated with proteinuria who underwent renal biopsy from January 2013 to September 2019 in 2 hospitals in Xuzhou were retrospectively collected. According to the pathological classification of kidney, 25 patients in group DKD and 34 patients in non-diabetic kidney disease (NDKD) group were divided into two groups. The admission information and blood biochemical indexes of all patients with renal biopsy were collected, and the TG / Cys-C ratio was calculated. Logistic regression analysis was used to analyze the related factors of DKD in patients with type 2 diabetes and proteinuria. Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of TG/Cys-C ratio for DKD in patients with type 2 diabetes and proteinuria. Another 37 patients with type 2 diabetes complicated by proteinuria who were treated in the Department of Nephrology, four hospitals in Xuzhou from October 2019 to October 2021 were selected as the research objects. The TG/Cys-C value cut-off value selected in the retrospective study was selected as the boundary point and divided into two groups according to the values of greater than or equal to the tangent point and less than the tangential point. Serum triglyceride and cystatin C levels were measured and TG / Cys-C ratio was calculated. All patients underwent ultrasound-guided fine-needle renal biopsy. The positive rates of DKD diagnosis in the two groups were compared to verify the predictive value of TG / Cys-C ratio in the diagnosis of DKD.
Retrospective study showed that compared with group NDKD, the DKD group had higher systolic blood pressure, higher cystatin C and creatinine, more diabetic retinopathy, longer duration of diabetes, lower hemoglobin concentration, lower glomerular filtration rate, lower cholesterol, lower triglyceride and lower TG/ Cys-C ratio (P < 0.05).Multivariate Logistic regression analysis showed that TG/Cys-C ratio (OR = 0.429, P = 0.009) was a protective factor for DKD in patients with type 2 diabetes and proteinuria. Diabetic retinopathy (OR = 7.054, P = 0.021) and systolic blood pressure (OR = 1.041, P = 0.047) were independent risk factors for DKD in patients with type 2 diabetes complicated with proteinuria. ROC curve showed that the area under the curve predicted by TG/Cys-C ratio for the diagnosis of DKD was 0.816, the sensitivity was 84%, and the specificity was 67.6%. The tangent value of TG / Cys-C ratio is 2.43. Prospective studies showed that in 37 patients with type 2 diabetes and proteinuria, 29 patients had a TG/Cys-C ratio of less than 2.43. The TG/Cys-C ratio of 8 patients was more than 2.43. Ultrasound guided fine needle aspiration biopsy revealed that 22 of the 29 patients had pathological diagnosis of DKD, sensitivity 91.67%, specificity 46.15%, positive predictive value 75.80%, and negative predictive value 75%.
In type 2 diabetic patients with proteinuria, the ratio of TG/Cys-C has certain predictive value for the diagnosis of DKD.
目前,在 2 型糖尿病中,缺乏能够准确区分糖尿病肾脏疾病(DKD)和非糖尿病肾脏疾病(NDKD)的临床指标。本研究旨在探讨甘油三酯和胱抑素 C(TG/Cys-C)比值在 DKD 中的诊断价值。目前,关于 TG/Cys-C 比值在 DKD 和 NDKD 中的鉴别诊断研究较少。
回顾性收集 2013 年 1 月至 2019 年 9 月在徐州市 2 家医院行肾活检的 2 型糖尿病伴蛋白尿患者的临床资料。根据肾脏病理分类,将 25 例 DKD 患者和 34 例非糖尿病肾病(NDKD)患者分为两组。收集所有患者肾活检的入院信息和血生化指标,并计算 TG/Cys-C 比值。采用 logistic 回归分析 2 型糖尿病伴蛋白尿患者 DKD 的相关因素。采用受试者工作特征(ROC)曲线评价 TG/Cys-C 比值对 2 型糖尿病伴蛋白尿患者 DKD 的诊断价值。另选取 2019 年 10 月至 2021 年 10 月徐州市 4 家医院肾内科收治的 37 例 2 型糖尿病伴蛋白尿患者作为研究对象。选取回顾性研究中选择的 TG/Cys-C 值截断值作为边界点,根据大于或等于切点和小于切点的值分为两组。测量血清甘油三酯和胱抑素 C 水平,并计算 TG/Cys-C 比值。所有患者均行超声引导下肾穿刺活检。比较两组患者 DKD 诊断的阳性率,以验证 TG/Cys-C 比值对 DKD 诊断的预测价值。
回顾性研究显示,与 NDKD 组相比,DKD 组患者收缩压较高,胱抑素 C 和肌酐较高,糖尿病视网膜病变较多,糖尿病病程较长,血红蛋白浓度较低,肾小球滤过率较低,胆固醇较低,甘油三酯较低,TG/Cys-C 比值较低(P<0.05)。多因素 Logistic 回归分析显示,TG/Cys-C 比值(OR=0.429,P=0.009)是 2 型糖尿病伴蛋白尿患者 DKD 的保护因素。糖尿病视网膜病变(OR=7.054,P=0.021)和收缩压(OR=1.041,P=0.047)是 2 型糖尿病伴蛋白尿患者 DKD 的独立危险因素。ROC 曲线显示,TG/Cys-C 比值预测 DKD 的曲线下面积为 0.816,灵敏度为 84%,特异性为 67.6%。TG/Cys-C 比值的切点值为 2.43。前瞻性研究显示,在 37 例 2 型糖尿病伴蛋白尿患者中,29 例患者 TG/Cys-C 比值小于 2.43,8 例患者 TG/Cys-C 比值大于 2.43。超声引导下肾穿刺活检显示,29 例患者中有 22 例患者病理诊断为 DKD,灵敏度为 91.67%,特异性为 46.15%,阳性预测值为 75.80%,阴性预测值为 75%。
在 2 型糖尿病伴蛋白尿患者中,TG/Cys-C 比值对 DKD 的诊断具有一定的预测价值。